Human BMP2/BDA2/BMP2A ORF/cDNA clone-Lentivirus particle (NM_001200)
Cat. No.: vGMLP002836
Pre-made Human BMP2/BDA2/BMP2A Lentiviral expression plasmid for BMP2 lentivirus packaging, BMP2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
BMP2/BDA2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP002836 | Human BMP2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP002836 |
| Gene Name | BMP2 |
| Accession Number | NM_001200 |
| Gene ID | 650 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 1191 bp |
| Gene Alias | BDA2,BMP2A,SSFSC |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGTGGCCGGGACCCGCTGTCTTCTAGCGTTGCTGCTTCCCCAGGTCCTCCTGGGCGGCGCGGCTGGCCTCGTTCCGGAGCTGGGCCGCAGGAAGTTCGCGGCGGCGTCGTCGGGCCGCCCCTCATCCCAGCCCTCTGACGAGGTCCTGAGCGAGTTCGAGTTGCGGCTGCTCAGCATGTTCGGCCTGAAACAGAGACCCACCCCCAGCAGGGACGCCGTGGTGCCCCCCTACATGCTAGACCTGTATCGCAGGCACTCAGGTCAGCCGGGCTCACCCGCCCCAGACCACCGGTTGGAGAGGGCAGCCAGCCGAGCCAACACTGTGCGCAGCTTCCACCATGAAGAATCTTTGGAAGAACTACCAGAAACGAGTGGGAAAACAACCCGGAGATTCTTCTTTAATTTAAGTTCTATCCCCACGGAGGAGTTTATCACCTCAGCAGAGCTTCAGGTTTTCCGAGAACAGATGCAAGATGCTTTAGGAAACAATAGCAGTTTCCATCACCGAATTAATATTTATGAAATCATAAAACCTGCAACAGCCAACTCGAAATTCCCCGTGACCAGACTTTTGGACACCAGGTTGGTGAATCAGAATGCAAGCAGGTGGGAAAGTTTTGATGTCACCCCCGCTGTGATGCGGTGGACTGCACAGGGACACGCCAACCATGGATTCGTGGTGGAAGTGGCCCACTTGGAGGAGAAACAAGGTGTCTCCAAGAGACATGTTAGGATAAGCAGGTCTTTGCACCAAGATGAACACAGCTGGTCACAGATAAGGCCATTGCTAGTAACTTTTGGCCATGATGGAAAAGGGCATCCTCTCCACAAAAGAGAAAAACGTCAAGCCAAACACAAACAGCGGAAACGCCTTAAGTCCAGCTGTAAGAGACACCCTTTGTACGTGGACTTCAGTGACGTGGGGTGGAATGACTGGATTGTGGCTCCCCCGGGGTATCACGCCTTTTACTGCCACGGAGAATGCCCTTTTCCTCTGGCTGATCATCTGAACTCCACTAATCATGCCATTGTTCAGACGTTGGTCAACTCTGTTAACTCTAAGATTCCTAAGGCATGCTGTGTCCCGACAGAACTCAGTGCTATCTCGATGCTGTACCTTGACGAGAATGAAAAGGTTGTATTAAAGAACTATCAGGACATGGTTGTGGAGGGTTGTGGGTGTCGCTAG |
| ORF Protein Sequence | MVAGTRCLLALLLPQVLLGGAAGLVPELGRRKFAAASSGRPSSQPSDEVLSEFELRLLSMFGLKQRPTPSRDAVVPPYMLDLYRRHSGQPGSPAPDHRLERAASRANTVRSFHHEESLEELPETSGKTTRRFFFNLSSIPTEEFITSAELQVFREQMQDALGNNSSFHHRINIYEIIKPATANSKFPVTRLLDTRLVNQNASRWESFDVTPAVMRWTAQGHANHGFVVEVAHLEEKQGVSKRHVRISRSLHQDEHSWSQIRPLLVTFGHDGKGHPLHKREKRQAKHKQRKRLKSSCKRHPLYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPLADHLNSTNHAIVQTLVNSVNSKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T68383-Ab | Anti-BMP2/ BDA2A/ SSFSC monoclonal antibody |
| Target Antigen | GM-Tg-g-T68383-Ag | BMP2 VLP (virus-like particle) |
| Cytokine | cks-Tg-g-GM-T68383 | bone morphogenetic protein 2 (BMP2) protein & antibody |
| ORF Viral Vector | pGMLP002836 | Human BMP2 Lentivirus plasmid |
| ORF Viral Vector | pGMAD000553 | Human BMP2 Adenovirus plasmid |
| ORF Viral Vector | pGMAAV000460 | Human BMP2 Adeno-associate virus(AAV) plasmid |
| ORF Viral Vector | pGMLP-SPh-068 | Human BMP2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-208 | Human BMP2 Adenovirus plasmid |
| ORF Viral Vector | pGMPC001201 | Human BMP2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP002836 | Human BMP2 Lentivirus particle |
| ORF Viral Vector | vGMAD000553 | Human BMP2 Adenovirus particle |
| ORF Viral Vector | vGMAAV000460 | Human BMP2 Adeno-associate virus(AAV) particle |
| ORF Viral Vector | vGMLP-SPh-068 | Human BMP2 Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-208 | Human BMP2 Adenovirus particle |
Target information
| Target ID | GM-T68383 |
| Target Name | BMP2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
650 |
| Gene ID |
100051701 (Equus caballus), 100301987 (Felis catus), 12156 (Mus musculus), 29373 (Rattus norvegicus) 477162 (Canis lupus familiaris), 615037 (Bos taurus), 650 (Homo sapiens), 718330 (Macaca mulatta) |
| Gene Symbols & Synonyms | BMP2,Bmp2,Bmp2a,BDA2,BMP2A,SSFSC,SSFSC1 |
| Target Alternative Names | BDA2,BMP-2,BMP2,BMP2A,Bmp2,Bmp2a,Bone morphogenetic protein 2,Bone morphogenetic protein 2A (BMP-2A),SSFSC,SSFSC1 |
| Uniprot Accession |
P12643,P21274,P49001
Additional SwissProt Accessions: P21274,P49001,P12643 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, TGF-beta signaling pathway, Hippo signaling pathway, Pathways in cancer, Basal cell carcinoma |
| Gene Ensembl | ENSECAG00000021201, ENSMUSG00000027358, ENSCAFG00845027004, ENSBTAG00000005111, ENSG00000125845, ENSMMUG00000064170 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


